bcl‐2 expression and prognosis in squamous‐cell carcinomas of the esophagus

No abstract is available for this paper.

• Publication year

  1996

• Venue

  International Journal of Cancer

• Publication date

  1996-08-22

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/(SICI)1097-0215(19960822)69:4<324::AID-IJC15>3.0.CO;2-5PMID 8797876
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression and prognostic significance of Bcl-2 in ovarian tumours.

  1995cited by this paper
• The possible role of bcl–2 expression in the progression of tumors of the uterine cervix

  1995cited by this paper
• Expression of the apoptosis‐suppressing protein Bcl‐2 in non‐melanoma skin cancer

  1995cited by this paper
• The bcl-2 proto-oncogene and the gastrointestinal epithelial tumor progression model.

  1995cited by this paper
• Prognostic value of bcl-2 oncoprotein expression in stage II colon carcinoma.

  1995cited by this paper
• Immunohistochemically detectable bcl-2 expression in colorectal carcinoma: correlation with tumour stage and patient survival.

  1995cited by this paper
• Expression of bcl-2 protein in stage T1NOMO non-small cell lung carcinoma

  1995cited by this paper
• Expression of bcl-2 protein in stage T1N0M0 non-small cell lung carcinoma.

  1995cited by this paper
• bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis.

  1995cited by this paper
• bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer.

  1994cited by this paper
• Immunohistochemical evidence of aberrant bcl‐2 protein expression in gastric epithelial dysplasia

  1994cited by this paper
• The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients.

  1994cited by this paper
• Bcl-2 protein expression and long-term survival in breast cancer.

  1994cited by this paper
• Bcl-2 oncogene blocks differentiation and extends viability but does not immortalize normal human keratinocytes.

  1994cited by this paper
• bcl-2 protein in non-small-cell lung carcinoma.

  1993cited by this paper
• Expression of bcl-2-like immunoreactivity in the normal breast and in breast cancer

  1993cited by this paper
• Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers.

  1993cited by this paper
• BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death.

  1991cited by this paper
• Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18)

  1991cited by this paper
• Oncogenic potential of bcl-2 demonstrated by gene transfer

  1988cited by this paper
• The bcl-2 gene is rearranged in many diffuse B-cell lymphomas.

  1988cited by this paper
• Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18.

  1985cited by this paper
• The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining.

  1985cited by this paper
• Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

  1981cited by this paper
• Intraepithelial carcinoma concomitant with esophageal carcinoma

  1962cited by this paper

• Epithelial and mesenchymal compartments of the developing bladder and urethra display spatially distinct gene expression patterns

  2025cites this paper
• Potential Role of Silencing Ribonucleic Acid for Esophageal Cancer Treatment.

  2022cites this paper
• The potential of proliferative and apoptotic parameters in clinical flow cytometry of myeloid malignancies.

  2021cites this paper
• miRNA-1207-5p is associated with cancer progression by targeting stomatin-like protein 2 in esophageal carcinoma

  2015cites this paper
• miRNA-1207-5p is associated with cancer progression by targeting stomatin-like protein 2 in esophageal carcinoma.

  2015cites this paper
• Immunohistochemical Detection of P53 and Bcl-2 in Esophageal Tumors

  2015cites this paper
• Immunohistochemical Expression of P 53 and Bcl-2 In Esophageal Tumors نع

  2015cites this paper
• The Role of Glycogen Synthase Kinase 3-β in Immunity and Cell Cycle: Implications in Esophageal Cancer

  2013cites this paper
• MiR-429 up-regulation induces apoptosis and suppresses invasion by targeting Bcl-2 and SP-1 in esophageal carcinoma

  2013cites this paper
• Chapter 14 – Immunohistology of the Gastrointestinal Tract

  2011cites this paper
• {2-[(3-Carboxy-1-oxopropyl) amino]-2-deoxy-d-Glucose} suppresses proliferation and induces apoptosis in the human esophageal cancer cell line

  2011cites this paper
• Apoptosis in Carcinogenesis and Chemotherapy – Esophageal Cancer

  2009cites this paper
• Biomarkers of apoptosis and survival in esophageal squamous cell carcinoma

  2009cites this paper
• S 100 A 2 Overexpression is Frequently Observed in Esophageal Squamous Cell Carcinoma

  2009cites this paper
• Transcription regulation and candidate diagnostic markers of esophageal cancer

  2009influential citation
• Apoptosis in Carcinogenesis and Chemotherapy

  2009cites this paper
• Low Expression of Bax Predicts Poor Prognosis in Patients with Locally Advanced Esophageal Cancer Treated with Definitive Chemoradiotherapy

  2007cites this paper
• Advances in Brief Up-Regulation of Fas ( APO-1 / CD 95 ) Ligand and Down-Regulation of Fas Expression in Human Esophageal Cancer 1

  2006cites this paper
• Fas and WAF1 expression in esophageal squamous cell carcinomas.

  2006cites this paper
• Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 147 Predictive Factors in Esophageal Carcinoma

  2006cites this paper
• Predictive factors in esophageal carcinoma.

  2006cites this paper
• Chapter 13 – Immunohistochemistry of the Gastrointestinal Tract, Pancreas, Bile Ducts, Gallbladder and Liver

  2006cites this paper
• Colorectal Tumor Xenografts Prodrug Therapy That Results in Tumor Regressions in ZD2767, an Improved System for Antibody-directed Enzyme

  2006cites this paper
• tt-Difluoromethylornithine Inhibits W-Nitrosomethylbenzylamine-induced Esophageal Carcinogenesis in Zinc-deficient Rats: Effects on Esophageal Cell Proliferation and Apoptosis1

  2006cites this paper
• Expression of Bcl-XL , an Antiapoptotic Member of the Bcl-2 Family , in Esophageal Squamous Cell Carcinoma ’

  2005cites this paper
• S100A2 overexpression is frequently observed in esophageal squamous cell carcinoma.

  2005cites this paper
• C-Myc And Bcl-2 Expression In Supraglottic Squamous Cell Carcinoma of the Larynx

  2004cites this paper
• Recent Results in Understanding Molecular Pathways in the Medical Treatment of Esophageal and Gastric Cancer

  2004cites this paper
• Bcl‐X expression in esophageal squamous cell carcinoma: Association with tumor progression and prognosis

  2001cites this paper
• Prognostic significance of CyclinD1 and E-Cadherin in patients with esophageal squamous cell carcinoma: multiinstitutional retrospective analysis. Research Committee on Malignancy of Esophageal Cancer, Japanese Society for Esophageal Diseases.

  2001cites this paper
• Bax and Bcl-X(L) expression are not related to prognosis in patients with advanced esophageal squamous cell carcinoma.

  2001cites this paper
• Expression of apoptosis-regulating proteins p53, Bcl-2, and Bax in primary resected esophageal squamous cell carcinoma.

  2001cites this paper
• AIS overexpression in advanced esophageal cancer.

  2001cites this paper
• Expression of apoptosis-related proteins and response to chemoradiotherapy and prognosis in esophageal cancer

  2000cites this paper
• Immunolocalizaiton of c-Myc and bcl-2 proto-oncogene products in gingival hyperplasia induced by nifedipine and phenytoin.

  2000cites this paper
• Expression and clinical implications of bcl-2 in extrahepatic bile duct carcinoma: its relationship with biological features.

  2000cites this paper
• bcl-2 Expression in Cholangiocellular Carcinoma Is Inversely Correlated with Biologically Aggressive Phenotypes

  2000cites this paper
• Dysregulated expression of bcl-2 and bax in oral carcinomas: evidence of post-transcriptional control.

  2000cites this paper
• Basaloid squamous carcinoma of the oesophagus: a distinct neoplasm with multipotential differentiation

  2000cites this paper
• Molecular biology of esophageal squamous cell carcinoma.

  2000cites this paper
• Apoptosis and predisposition to oral cancer.

  1999cites this paper
• Fas ligand and Fas receptor are coexpressed in normal human esophageal epithelium: a potential mechanism of apoptotic epithelial turnover.

  1999cites this paper
• Resistance to Fas (APO-1/CD95)-mediated apoptosis and expression of Fas ligand in esophageal cancer: the Fas counterattack.

  1999cites this paper
• Expression of Bcl-2 and amplification of c-myc are frequent in basaloid squamous cell carcinomas of the esophagus.

  1999cites this paper
• Prognostic factors of oesophageal squamous cell carcinoma from the perspective of molecular biology

  1999cites this paper
• Correlations of bcl-2 and p53 expression with the clinicopathological features in tongue squamous cell carcinomas.

  1999cites this paper
• Expression of Bcl-X(L), an antiapoptotic member of the Bcl-2 family, in esophageal squamous cell carcinoma.

  1998cites this paper
• Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer.

  1998cites this paper
• Prognostic value of bcl-2 expression in gastric cancer.

  1998cites this paper
• Alpha-difluoromethylornithine inhibits N-nitrosomethylbenzylamine-induced esophageal carcinogenesis in zinc-deficient rats: effects on esophageal cell proliferation and apoptosis.

  1998cites this paper
• Clinical relevance of p53 and bcl‐2 protein over‐expression in laryngeal squamous‐cell carcinoma

  1998cites this paper
• Expression of Bax, a pro‐apoptotic member of the Bcl‐2 family, in esophageal squamous cell carcinoma

  1997cites this paper
• Biology of esophageal cancer and the role of combined modality therapy.

  1997cites this paper
• ZD2767, an improved system for antibody-directed enzyme prodrug therapy that results in tumor regressions in colorectal tumor xenografts.

  1996cites this paper